Background rates of adverse events of special interest for COVID-19 vaccines: A multinational Global Vaccine Data Network (GVDN) analysis-Reference-Cited by-同舟云学术

Background rates of adverse events of special interest for COVID-19 vaccines: A multinational Global Vaccine Data Network (GVDN) analysis

Published:2023-10 Issue:42 Volume:41 Page:6227-6238
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Phillips A.^ORCID,Jiang Y.,Walsh D.,Andrews N.,Artama M.,Clothier H.,Cullen L.,Deng L.^ORCID,Escolano S.^ORCID,Gentile A.^ORCID,Gidding G.,Giglio N.,Junker T.,Huang W.^ORCID,Janjua N.,Kwong J.,Li J.,Nasreen S.^ORCID,Naus M.^ORCID,Naveed Z.,Pillsbury A.,Stowe J.,Vo T.^ORCID,Buttery J.^ORCID,Petousis-Harris H.,Black S.,Hviid A.^ORCID

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference38 articles.

1. WHO Coronavirus (COVID-19) Dashboard;World Health Organisation,2023

2. On the shoulders of giants — from jenner’s cowpox to mRNA covid vaccines;Desmond;N Engl J Med,2021

3. Methodological frontiers in vaccine safety: qualifying available evidence for rare events, use of distributed data networks to monitor vaccine safety issues, and monitoring the safety of pregnancy interventions;Dodd;BMJ Glob Health,2021

4. Evaluation of the safety profile of COVID-19 vaccines: a rapid review;Wu;BMC Med,2021

5. Signal assessment report on embolic and thrombotic events (SMQ) with COVID-19 Vaccine (ChAdOx1-S [recombinant]) – COVID-19 Vaccine AstraZeneca (other viral vaccines);European Medicines Agency,2021

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Validation of the newly proposed Brighton Collaboration case definition for vaccine-induced immune thrombocytopenia and thrombosis;Vaccine;2024-11

2. Establishing the Vaccine Safety Health Link: A large, linked data resource for the investigation of vaccine safety concerns;Australian and New Zealand Journal of Public Health;2024-10

3. Framework for Implementation of Poisson MaxSPRT Technique with Variations for Vaccine Safety;2024-07-25

4. Global Database Confirms Low Rates of Adverse Events Associated With COVID-19 Vaccines;Neurology Today;2024-04-04

5. Acute disseminated encephalomyelitis and transverse myelitis following COVID-19 vaccination – A self-controlled case series analysis;Vaccine;2024-04